| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/07/2001 | WO2001039794A1 Insulin-containing medicament for peroral application and method for the production thereof |
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001039769A1 Hypoglycemics comprising organic zinc (ii) complexes |
| 06/07/2001 | WO2001039766A2 Screening invertebrate pheromones for therapeutic activity |
| 06/07/2001 | WO2001039724A2 Phosphonate compounds |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001028557B1 Cannabimimetic indole derivatives |
| 06/07/2001 | WO2001012187A3 Benzoic acid derivatives and their use as ppar receptor agonists |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO1999002187A3 Decreased fat absorption with an anti-lipase antibody |
| 06/07/2001 | US20010003119 Edible, wholly or partially nondigestible low calorie fatty acid polyesters having non-Newtonian pseudoplastic rheology at body temperature; substitute for triglyceride fats in low calorie fat-containing foods; for reducing serum cholesterol |
| 06/07/2001 | US20010003002 As dietary supplement, for treating osteoporosis |
| 06/07/2001 | US20010002998 Over-coated chewing gum formulations including tableted center |
| 06/07/2001 | DE19952146A1 Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Arylalkanes, aryl alkenes and aryl azaalkane, pharmaceutical compositions containing them and methods for their preparation |
| 06/07/2001 | DE19948434A1 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amine |
| 06/07/2001 | CA2747954A1 Phosphonate compounds |
| 06/07/2001 | CA2393265A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 06/07/2001 | CA2393190A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | CA2392979A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline crystal |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2392795A1 Insulin-containing medicament for peroral application and method for the production thereof |
| 06/07/2001 | CA2392713A1 Novel antidiabetic agents |
| 06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | CA2392039A1 New tri-substituted phenyl derivatives and analogues |
| 06/07/2001 | CA2392038A1 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |
| 06/07/2001 | CA2392035A1 New phenalkyloxy-phenyl derivatives |
| 06/07/2001 | CA2392029A1 Comminuted form of (s)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid |
| 06/07/2001 | CA2391646A1 Solid preparation |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2327638A1 Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications |
| 06/07/2001 | CA2327575A1 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104438A2 Novel anti-diabetic peptides |
| 06/06/2001 | EP1104411A1 Calcilytic compounds |
| 06/06/2001 | EP1104408A2 Drug targeting |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | EP1104307A2 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/06/2001 | EP1104247A1 Process and product for promoting weight loss in overweight dogs |
| 06/06/2001 | EP0879058B1 Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments |
| 06/06/2001 | CN1298411A Caspase-8 interacting proteins |
| 06/06/2001 | CN1298404A Inhibitors of phospholipase A2 |
| 06/06/2001 | CN1298394A Aryl fused azapolycyclic compounds |
| 06/06/2001 | CN1298393A Quinoline derivatives |
| 06/06/2001 | CN1298386A N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders |
| 06/06/2001 | CN1298311A A drug composition containing sodium Pravastatin |
| 06/06/2001 | CN1297773A Production process for whole glossy ganoderma product |
| 06/06/2001 | CN1297772A Preparation of medicine for diabetes |
| 06/06/2001 | CN1297755A Externally dressed ointment for treating diabetes |
| 06/06/2001 | CN1297754A Tonic food capable of lowering blood lipoid, resisting senility and regulating immunity |
| 06/06/2001 | CN1297744A Chinese medicine for treating diabetes |
| 06/06/2001 | CN1297743A Buccal tablet of Qingqian Willow leaf |
| 06/06/2001 | CN1066734C Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 06/06/2001 | CN1066729C Benzimidazole derivatives, their producing process and its therapeutic use |
| 06/06/2001 | CN1066727C Anti-migraine indole derivative salts |
| 06/06/2001 | CN1066624C Dry mix formulation for bisphosphonic acids |
| 06/06/2001 | CA2328553A1 Novel derivatives (dihydro)benzoxazine and (dihydro)benzothiazine substitutes, process for preparing them and pharmaceutical compositions containing them |
| 06/05/2001 | US6242601 Heterocyclic sulfamides |
| 06/05/2001 | US6242479 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/05/2001 | US6242434 Treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders. |
| 06/05/2001 | US6242254 Cell has dna encoding tetracycline responsive transcriptional activator linked to tissue-specific promoter and tetracycline operator minimal promoter linked to dna encoding sv40 t antigen; cell proliferation is controlled by tetracycline |
| 06/05/2001 | US6242003 Organic compounds |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038503A2 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | WO2001038393A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 05/31/2001 | WO2001038355A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 05/31/2001 | WO2001038344A2 Modulation of signal transduction |
| 05/31/2001 | WO2001038326A2 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038320A1 Vitamin d analogues |
| 05/31/2001 | WO2001038314A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 05/31/2001 | WO2001038313A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p39 kINASE INHIBITORS |
| 05/31/2001 | WO2001038312A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001038311A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | WO2001038303A2 Vitamin d analogues |
| 05/31/2001 | WO2001038295A1 Sphingosine derivatives |
| 05/31/2001 | WO2001037877A1 Remedies for diseases in association with decrease in bone mass |
| 05/31/2001 | WO2001037870A1 Treatment of autoimmune diseases by an agonistic cd40-binding protein |
| 05/31/2001 | WO2001037868A1 Assays and therapies for latent viral infection |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037856A1 Urotensin-ii cyclic analogs |
| 05/31/2001 | WO2001037842A1 Remedies for periodontosis |
| 05/31/2001 | WO2001037837A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001037831A1 PHARMACEUTICAL COMBINATION COMPRISING SEPARATE DOSAGE FORMS IN A COMPLIANCE PACKAGE OF AN INHIBITOR OF HMG CoA REDUCTASE AND FIBRIC ACID DERIVATIVE |
| 05/31/2001 | WO2001037827A1 Therapeutic intervention to mimic the effect of caloric restriction |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/31/2001 | WO2001037820A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 05/31/2001 | WO2001037819A2 Use of indirubine derivatives for making medicines |
| 05/31/2001 | WO2001037809A1 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 05/31/2001 | WO2001037808A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | WO2001037782A2 Method and composition for the treatment of scars |
| 05/31/2001 | WO2001037780A2 Urotensin-ii analogs |
| 05/31/2001 | WO2001037681A1 Phytosterol and phytostanol compositions |
| 05/31/2001 | WO2001002598A3 Screening for compounds modulating mitochondrial proton leak |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000073307A3 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors |